...
holx-img

Hologic Inc, Common Stock

HOLX

NSQ

$75.79

+$0.45

(0.6%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$17.10B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
22.6928
Volume info-icon
This is the total number of shares traded during the most recent trading day.
2.22M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.99
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$68.15 L
$84.67 H
$75.79

About Hologic Inc, Common Stock

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameHOLXSectorS&P500
1-Week Return-4.06%-1.95%0.69%
1-Month Return-4.53%-3.36%1.53%
3-Month Return-8.34%-6.93%11.27%
6-Month Return2.46%-1.83%13.49%
1-Year Return10.35%8.53%31.62%
3-Year Return0.8%7.58%30.33%
5-Year Return45.47%44.7%93.83%
10-Year Return180.96%103.96%195.13%

Financials

Sep '20Sep '21Sep '22Sep '23Sep '245YR TREND
Total Revenue3.78B5.63B4.86B4.03B4.03B[{"date":"2020-09-30","value":67.05,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":86.34,"profit":true},{"date":"2023-09-30","value":71.56,"profit":true},{"date":"2024-09-30","value":71.56,"profit":true}]
Cost of Revenue1.55B1.84B1.87B1.96B1.80B[{"date":"2020-09-30","value":79.07,"profit":true},{"date":"2021-09-30","value":93.75,"profit":true},{"date":"2022-09-30","value":95.23,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2024-09-30","value":92.02,"profit":true}]
Gross Profit2.23B3.80B3.00B2.07B2.23B[{"date":"2020-09-30","value":58.68,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":78.97,"profit":true},{"date":"2023-09-30","value":54.57,"profit":true},{"date":"2024-09-30","value":58.69,"profit":true}]
Gross Margin58.98%67.39%61.64%51.40%55.28%[{"date":"2020-09-30","value":87.52,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":91.46,"profit":true},{"date":"2023-09-30","value":76.26,"profit":true},{"date":"2024-09-30","value":82.02,"profit":true}]
Operating Expenses1.10B1.31B1.37B1.31B1.35B[{"date":"2020-09-30","value":80.7,"profit":true},{"date":"2021-09-30","value":96.07,"profit":true},{"date":"2022-09-30","value":100,"profit":true},{"date":"2023-09-30","value":95.86,"profit":true},{"date":"2024-09-30","value":98.43,"profit":true}]
Operating Income1.10B2.48B1.64B668.40M882.60M[{"date":"2020-09-30","value":44.55,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":66.13,"profit":true},{"date":"2023-09-30","value":26.95,"profit":true},{"date":"2024-09-30","value":35.58,"profit":true}]
Total Non-Operating Income/Expense(215.30M)(211.40M)(134.20M)17.10M-[{"date":"2020-09-30","value":-1259.06,"profit":false},{"date":"2021-09-30","value":-1236.26,"profit":false},{"date":"2022-09-30","value":-784.8,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Pre-Tax Income1.00B2.36B1.59B676.10M865.10M[{"date":"2020-09-30","value":42.43,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":67.27,"profit":true},{"date":"2023-09-30","value":28.63,"profit":true},{"date":"2024-09-30","value":36.64,"profit":true}]
Income Taxes(108.60M)491.40M286.20M220.10M75.60M[{"date":"2020-09-30","value":-22.1,"profit":false},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":58.24,"profit":true},{"date":"2023-09-30","value":44.79,"profit":true},{"date":"2024-09-30","value":15.38,"profit":true}]
Income After Taxes1.11B1.87B1.30B456.00M-[{"date":"2020-09-30","value":59.39,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":69.64,"profit":true},{"date":"2023-09-30","value":24.39,"profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Income From Continuous Operations1.11B1.87B1.30B456.00M-[{"date":"2020-09-30","value":59.39,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":69.64,"profit":true},{"date":"2023-09-30","value":24.39,"profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Income From Discontinued Operations-----[{"date":"2020-09-30","value":"-","profit":true},{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Net Income1.12B1.87B1.30B456.00M789.50M[{"date":"2020-09-30","value":59.59,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":69.57,"profit":true},{"date":"2023-09-30","value":24.37,"profit":true},{"date":"2024-09-30","value":42.19,"profit":true}]
EPS (Diluted)4.008.396.013.954.08[{"date":"2020-09-30","value":47.68,"profit":true},{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":71.63,"profit":true},{"date":"2023-09-30","value":47.08,"profit":true},{"date":"2024-09-30","value":48.63,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

HOLX
Cash Ratio 2.25
Current Ratio 3.69
Quick Ratio 3.03

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

HOLX
ROA (LTM) 6.45%
ROE (LTM) 13.85%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

HOLX
Debt Ratio Lower is generally better. Negative is bad. 0.44
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.56

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

HOLX
Trailing PE 22.83
Forward PE 17.67
P/S (TTM) 4.31
P/B 3.33
Price/FCF 51
EV/R 4.32
EV/Ebitda 13.44
PEG 1.21

FAQs

What is Hologic Inc share price today?

Hologic Inc (HOLX) share price today is $75.79

Can Indians buy Hologic Inc shares?

Yes, Indians can buy shares of Hologic Inc (HOLX) on Vested. To buy Hologic Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in HOLX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Hologic Inc be purchased?

Yes, you can purchase fractional shares of Hologic Inc (HOLX) via the Vested app. You can start investing in Hologic Inc (HOLX) with a minimum investment of $1.

How to invest in Hologic Inc shares from India?

You can invest in shares of Hologic Inc (HOLX) via Vested in three simple steps:

  • Click on Sign Up or Invest in HOLX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Hologic Inc shares
What is Hologic Inc 52-week high and low stock price?

The 52-week high price of Hologic Inc (HOLX) is $84.67. The 52-week low price of Hologic Inc (HOLX) is $68.15.

What is Hologic Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Hologic Inc (HOLX) is 22.6928

What is Hologic Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Hologic Inc (HOLX) is 3.33

What is Hologic Inc dividend yield?

The dividend yield of Hologic Inc (HOLX) is 0.00%

What is the Market Cap of Hologic Inc?

The market capitalization of Hologic Inc (HOLX) is $17.10B

What is Hologic Inc’s stock symbol?

The stock symbol (or ticker) of Hologic Inc is HOLX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top